Diaz-Cruz ES - Search Results

1

Aromatase inhibitors in the treatment of breast cancer.

Brueggemeier RW, Hackett JC, Diaz-Cruz ES. Brueggemeier RW, et al. Endocr Rev. 2005 May;26(3):331-45. doi: 10.1210/er.2004-0015. Epub 2005 Apr 6. Endocr Rev. 2005. PMID: 15814851 Review.

2

Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches.

Brueggemeier RW, Díaz-Cruz ES. Brueggemeier RW, et al. Minerva Endocrinol. 2006 Mar;31(1):13-26. Minerva Endocrinol. 2006. PMID: 16498361 Review.

3

Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells.

Díaz-Cruz ES, Shapiro CL, Brueggemeier RW. Díaz-Cruz ES, et al. J Clin Endocrinol Metab. 2005 May;90(5):2563-70. doi: 10.1210/jc.2004-2029. Epub 2005 Feb 1. J Clin Endocrinol Metab. 2005. PMID: 15687328

4

Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer.

Brueggemeier RW, Díaz-Cruz ES, Li PK, Sugimoto Y, Lin YC, Shapiro CL. Brueggemeier RW, et al. J Steroid Biochem Mol Biol. 2005 May;95(1-5):129-36. doi: 10.1016/j.jsbmb.2005.04.013. J Steroid Biochem Mol Biol. 2005. PMID: 15964185

5

Lead optimization of 7-benzyloxy 2-(4'-pyridylmethyl)thio isoflavone aromatase inhibitors.

Su B, Hackett JC, Díaz-Cruz ES, Kim YW, Brueggemeier RW. Su B, et al. Bioorg Med Chem. 2005 Dec 1;13(23):6571-7. doi: 10.1016/j.bmc.2005.07.038. Epub 2005 Aug 24. Bioorg Med Chem. 2005. PMID: 16125392

6

Novel sulfonanilide analogues suppress aromatase expression and activity in breast cancer cells independent of COX-2 inhibition.

Su B, Diaz-Cruz ES, Landini S, Brueggemeier RW. Su B, et al. J Med Chem. 2006 Feb 23;49(4):1413-9. doi: 10.1021/jm051126f. J Med Chem. 2006. PMID: 16480277

7

Interrelationships between cyclooxygenases and aromatase: unraveling the relevance of cyclooxygenase inhibitors in breast cancer.

Díaz-Cruz ES, Brueggemeier RW. Díaz-Cruz ES, et al. Anticancer Agents Med Chem. 2006 May;6(3):221-32. doi: 10.2174/187152006776930873. Anticancer Agents Med Chem. 2006. PMID: 16712450 Review.

8

Aromatase and COX in breast cancer: enzyme inhibitors and beyond.

Brueggemeier RW, Su B, Sugimoto Y, Díaz-Cruz ES, Davis DD. Brueggemeier RW, et al. J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):16-23. doi: 10.1016/j.jsbmb.2007.05.021. Epub 2007 May 25. J Steroid Biochem Mol Biol. 2007. PMID: 17616393 Free PMC article.

9

Evaluation of synthetic isoflavones on cell proliferation, estrogen receptor binding affinity, and apoptosis in human breast cancer cells.

Davis DD, Díaz-Cruz ES, Landini S, Kim YW, Brueggemeier RW. Davis DD, et al. J Steroid Biochem Mol Biol. 2008 Jan;108(1-2):23-31. doi: 10.1016/j.jsbmb.2007.07.001. Epub 2007 Sep 7. J Steroid Biochem Mol Biol. 2008. PMID: 17962013 Free PMC article.

10

Suppression of aromatase in human breast cells by a cyclooxygenase-2 inhibitor and its analog involves multiple mechanisms independent of cyclooxygenase-2 inhibition.

Su B, Díaz-Cruz ES, Landini S, Brueggemeier RW. Su B, et al. Steroids. 2008 Jan;73(1):104-11. doi: 10.1016/j.steroids.2007.09.011. Epub 2007 Oct 18. Steroids. 2008. PMID: 18045633 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters